Ranbaxy Chairman Tsutomu Une speaks during a news conference in New Delhi April 25, 2012. Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduce it in other Asian countries, Africa and South America.